相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum Disorder
Stanislas Demuth et al.
NEUROLOGY (2023)
New therapies for neuromyelitis optica spectrum disorder
Michael Levy et al.
LANCET NEUROLOGY (2021)
Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial
Masayuki Tahara et al.
LANCET NEUROLOGY (2020)
Treatment and outcome of aquaporin-4 antibody-positive NMOSD: A multinational pediatric study
Renata Barbosa Paolilo et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
Jacqueline Palace et al.
BRAIN (2019)
Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica
Richard K. Burt et al.
NEUROLOGY (2019)
Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
Takashi Yamamura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica Multicenter Study of Treatment Efficacy
Maureen A. Mealy et al.
JAMA NEUROLOGY (2014)
A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder
Su-Hyun Kim et al.
JAMA NEUROLOGY (2013)